Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHI 621 in renal transplantation.
Autor: | Kovarik JM; Sandoz Pharma Ltd., Basle, Switzerland., Rawlings E, Sweny P, Fernando O, Moore R, Griffin PJ, Fauchald P, Albrechtsen D, Sodal G, Nordal K, Amlot PL |
---|---|
Jazyk: | angličtina |
Zdroj: | Transplantation proceedings [Transplant Proc] 1996 Apr; Vol. 28 (2), pp. 913-4. |
Databáze: | MEDLINE |
Externí odkaz: |